Milestone in Phase III Clinical Trial of Hydronidone (F351) of Gyre Pharmaceuticals
2024-10-23
Gyre Pharmaceuticals (also known as Beijing Continent Pharmaceuticals) announced the succe...
Study on Pirfenidone for Treating Radiation-Induced Lung Injury Shined at ASTRO 2024
2024-10-18
From September 29 to October 2, 2024, the 66th Annual Meeting of the American Society for ...
GYRE Pharmaceuticals Co., Ltd. is Honored to be Included in the National “Little Giant” Enterprises that Use Specialized and Sophisticated Technologies to Produce Novel and Unique Products
2024-09-19
Recently, the Beijing Municipal Bureau of Economy and Information Technology officially an...